By Professor Ric Day

Journal articles

RAY JE; WADE DN; GRAHAM GG; DAY RO, 1979, 'Pharmacokinetics of Carprofen in Plasma and Synovial Fluid', Journal of Clinical Pharmacology, 19, pp. 635 - 643, http://dx.doi.org/10.1002/j.1552-4604.1979.tb01626.x

Graham G; Champion GD; Day RO, 1979, 'The pharmacokinetics of salicyclate in patients with rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, 6, pp. 194

Day RO; Wade DN, 1978, 'Influence of flufenamic acid and calcium ion concentration on the histamine release from rat mast cells induced by compound 48/80 and the calcium ionophore A23187', Biochemical Pharmacology, 27, pp. 1385 - 1387, http://dx.doi.org/10.1016/0006-2952(78)90126-0

Champion GD; Day RO; Paull PD; Graham GG; Owen MS; Haski AL; Hills L, 1978, 'Clinical Pharmacology and Efficacy of Benorylate in Patients with Rheumatoid Arthritis', Australian and New Zealand Journal of Medicine, 8, pp. 22 - 28, http://dx.doi.org/10.1111/j.1445-5994.1978.tb02398.x

Day RO; Wade DN, 1978, 'EFFECTS OF VARIOUS DRUGS ON THE OSMOTIC LYSIS OF RAT MAST CELLS', Clinical and Experimental Pharmacology and Physiology, 5, pp. 477 - 485, http://dx.doi.org/10.1111/j.1440-1681.1978.tb00700.x

Day RO; Wade DN, 1978, 'THE EFFECT OF VARIOUS DRUGS ON ADENOSINE TRIPHOSPHATE CONTENT AND HISTAMINE RELEASE FROM RAT PERITONEAL CELL SUSPENSIONS RICH IN MAST CELLS', Clinical and Experimental Pharmacology and Physiology, 5, pp. 223 - 227, http://dx.doi.org/10.1111/j.1440-1681.1978.tb00675.x

Day RO; Champion GD; Wade DN, 1978, 'The effect of various drugs on compound 48/80 and osmotic shock-induced histamine release from rat peritoneal cells', Clinical and Experimental Pharmacology and Physiology, 5, pp. 241 - 242

Bowden GJ; Day RK, 1977, 'A novel low temperature rearrangement of atoms in the rare earth intermetallic compound ErFe3', Journal of Physics F Metal Physics, 7, pp. 181 - 190, http://dx.doi.org/10.1088/0305-4608/7/1/027

Bowden GJ; Day RK, 1977, 'On the magnetic anomaly in ErFe3 at 47K', Journal of Physics F Metal Physics, 7, pp. 191 - 197, http://dx.doi.org/10.1088/0305-4608/7/1/028

Graham GG; Champion GD; Day RO; Kaski AL; Hills LG; Paull PD, 1977, 'Salicylates in rheumatoid arthritis: pharmacokinetics and analgesic response.', Agents and Actions Supplements, pp. 37 - 42

Day RO; Paull PD; Ray JE; Wade DN, 1977, 'The measurement of histamine release from suspensions of rat peritoneal cells rich in mast cells', Agents and Actions, 7, pp. 431 - 436, http://dx.doi.org/10.1007/BF01966848

Day RK; Bowden GJ, 1977, 'Magnetic anomalies in ErFe3', Physica B C, 86-88, pp. 71 - 72, http://dx.doi.org/10.1016/0378-4363(77)90230-3

Graham GG; Champion GD; Day RO; Paull PD, 1977, 'Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis', Clinical Pharmacology and Therapeutics, 22, pp. 410 - 420, http://dx.doi.org/10.1002/cpt1977224410

Grahm GG; Champion GD; Day RO, 1977, 'Salicylates in rheumatoid arthritis: Pharmacokinetics and analgesic responses', Agents and Actions, 7, pp. 35 - 42

Champion GD; Day RO; Fagan N, 1977, 'Single dose comparison of analgesic action of acetylsalicylate and sodium salicylate in rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, 4, pp. 213

Champion GD; Corrigan AB; Day RO, 1977, 'The effect of enteric coating of aspirin tablets on occult gastrointestinal blood loss', Clinical and Experimental Pharmacology and Physiology, 4, pp. 214 - 215

Day RO; Ray JE; Champion GD; Wade DN, 1977, 'The effect of non steroidal anti inflammatory drugs on ATP levels and histamine release from rat peritoneal cell suspension rich in mast cells', Clinical and Experimental Pharmacology and Physiology, 4, pp. 212 - 213

CHAMPION GD; DAY RO; RAY JE; WADE DN, 1977, 'THE EFFECT OF NON‐STEROIDAL ANTI‐INFLAMMATORY DRUGS ON ADENOSINE TRIPHOSPHATE CONTENT AND HISTAMINE RELEASE FROM RAT PERITONEAL CELL SUSPENSIONS RICH IN MAST CELLS', British Journal of Pharmacology, 59, pp. 29 - 33, http://dx.doi.org/10.1111/j.1476-5381.1977.tb06973.x

Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG, 1977, 'The Effects of Enteric Coating of Aspirin Tablets on Occult Gastrointestinal Blood Loss', Australian and New Zealand Journal of Medicine, 7, pp. 600 - 604, http://dx.doi.org/10.1111/j.1445-5994.1977.tb02315.x

Graham G; Champion GD; Day RO; Paull PD, 1977, 'The pharmacokinetics of salicylate in patients with rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, 4, pp. 214

Day RO; Paull PD; Champion GD; Graham GG, 1976, 'Evaluation of an Enteric Coated Aspirin Preparation', Australian and New Zealand Journal of Medicine, 6, pp. 45 - 50, http://dx.doi.org/10.1111/j.1445-5994.1976.tb03290.x

Paull P; Day R; Graham G; Champion D, 1976, 'Single dose evaluation of a new enteric coated aspirin preparation', Medical Journal of Australia, 1, pp. 617 - 619, http://dx.doi.org/10.5694/j.1326-5377.1976.tb140908.x

Paull PD; Day RO; Graham GG; Champion GD, 1975, 'Bioavailability of enteric coated aspirin', Clinical and Experimental Pharmacology and Physiology, 2, pp. 442

CHAMPION GD; DAY RO; GRAHAM GG; PAULL PD, 1975, '3 Salicylates in Rheumatoid Arthritis', Clinics in Rheumatic Diseases, 1, pp. 245 - 265, http://dx.doi.org/10.1016/s0307-742x(21)00120-x

Conference Papers

Chroinin DN; Premachandra K; Aung E; Girgis L; Day R; Penglase R; Refaat S; Napit S, 2025, 'Comparison of older and younger hospitalised patients with gout: A retrospective chart review', in AUSTRALASIAN JOURNAL ON AGEING, WILEY

Wabe N; Huang G; Silva S; Nguyen A; Seaman K; Raban MZ; Gates P; Day R; Close J; Lord S; Westbrook J, 2024, 'Patterns of Fall-Risk Increasing Drugs (FRIDs) Use and Associations with Falls in Residential Aged Care: A Group-Based Multi-Trajectory Analysis of An 8-Year Longitudinal Cohort Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 44 - 45

Wright D; Michael T; Chan J; Coleshill M; Aslani P; Hughes D; Day R; Stocker S, 2024, 'Patterns of suboptimal allopurinol implementation: impact on gout outcomes', in INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, SPRINGER, pp. 339 - 339

Michael T; Chan J; Wright D; Coleshill M; Aslani P; Hughes D; Day R; Stocker S, 2023, 'Patient-led urate self-monitoring to improve allopurinol persistence and clinical outcomes in people with gout: a pilot study', in BRITISH JOURNAL OF PHARMACOLOGY, WILEY, SCOTLAND, Glasgow, pp. 288 - 290, presented at 19th World Congress of Basic and Clinical Pharmacology (WCP), SCOTLAND, Glasgow, 02 July 2023 - 07 July 2023

Michael T; Spragg J; Aslani P; Coleshill M; Chan JS; Day R; Stocker S, 2023, 'Optimising adherence to allopurinol through patient-led self-monitoring urate concentrations: gaining gout patient perspectives', in INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, SPRINGER

Selvadurai D; Aung E; Coleshill M; Briggs N; Schulz M; Day R, 2023, 'PATIENT FACTORS AND HEALTH OUTCOMES ASSOCIATED WITH ILLNESS PERCEPTIONS IN PEOPLE WITH GOUT', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 18 - 18

Tiku A; Boudville N; Brown F; Cass A; Clarke P; Day R; de Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones G; Kanellis J; Pascoe E; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker R; Walters G; Johnson D; Badve S; Dalbeth N, 2021, 'Urate-lowering Therapy for Prevention of Gout: Prespecified Analyses from the CKD-FIX Trial', in ARTHRITIS & RHEUMATOLOGY, WILEY, ELECTR NETWORK, pp. 1372 - 1373, presented at ACR Convergence Conference, ELECTR NETWORK, 05 November 2021 - 09 November 2021

Mao C; Coleshill M; Day RO; Aung E, 2021, 'ADHERENCE TO URATE LOWERING THERAPY AMONG PEOPLE WITH GOUT IN AUSTRALIA', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 49 - 49, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000651518500135&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day RO; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones GR; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE KIDNEY FUNCTION: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200189&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Aung E; Coleshill M; Schulz M; Kamel B; Stocker S; Day R, 2020, 'RECRUITING PEOPLE WITH GOUT INTO A CLINICAL TRIAL IN PRIMARY CARE: THE GAPP EXPERIENCE', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 42 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000553988700116&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Simic M; Harmer A; van der Esch M; Bennell K; Ferreira P; March L; Fransen M; Day R, 2019, 'Do non-steroidal anti-inflammatory drugs cause osteoarthritis progression, a systematic review and meta analysis', in Osteoarthritis and Cartilage, Elsevier, pp. s280 - s282, http://dx.doi.org/10.1016/j.joca.2019.02.663

Manollaras K; Nolan L; Day R; Norris R; Dear R, 2016, 'EFFICACY OF SCALP COOLING AND PHARMACOKINETICS AT THE KINGHORN CANCER CENTRE, ST VINCENT'S HOSPITAL', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 168 - 168, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387769900313&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Martinello M; Schteinman A; Alavi M; Williams K; Dore GJ; Day R; Matthews GV, 2014, 'The impact of ribavirin plasma concentration on the eficacy of the interferon-sparing regimen, sofosbuvir and ribavirin', in Antiviral Therapy, SAGE Publications, MA, Boston, pp. 127 - 132, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, http://dx.doi.org/10.3851/IMP2984

Baysari MT; Westbrook JI; Egan B; Day RO, 2013, 'Identification of strategies to reduce computerized alerts in an electronic prescribing system using a Delphi approach', in Lehmann CU; Ammenwerth E; Nøhr C (eds.), IOS Press, Amsterdam, pp. 8 - 12, http://dx.doi.org/10.3233/978-1-61499-289-9-8

Lipworth WL; Kerridge IH; Day RO, 2012, 'Evidence-based medicine, resource allocation, and the persisting problem of ethically contested outcomes', Dunedin, New Zealand, presented at New Zealand Bioethics Conference, Dunedin, New Zealand

Westbrook J; Reckmann M; Li L; Day RO, 2011, 'The effectiveness of two commercial prescribing systems to reduce medication errors in hospital', Melbourne, Australia, presented at Annual Conference of the Australasian Association for Quality in Health Care (AAQHC), Melbourne, Australia, 12 October 2011 - 14 October 2011

Baysari MT; Westbrook J; Day RO, 2011, 'Ethnographic observation as a method of investigating alert fatigue', in Proceedings of the 5th International Symposium on Human Factors Engineering in Health Informatics, Tapir Academic Press, Trondheim, Norway, pp. 71 - 76, presented at 5th Human factors engineering, Trondheim, Norway, 26 August 2011 - 27 August 2011

Baysari MT; Westbrook J; Day RO, 2010, 'THE IMPACT OF COMPUTERISED DECISION SUPPORT ON SELECTING MEDICINES FOR PRESCRIPTION', Melbourne, Australia, presented at ASCEPT Annual Scientific meeting, Melbourne, Australia, 28 November 2010 - 01 December 2010

Westbrook J; Lo C; Reckmann M; Runciman W; Braithwaite J; Day RO, 2010, 'The effectiveness of an electronic medication management system to reduce prescribing errors in hospital', in 18th Annual Health Informatics Conference, Health Informatics Society of Australia, Mebourne, pp. 1 - 8, presented at HIC 2010, 18th National Health Informatics Conference, Melbourne, Australia, 24 August 2010 - 26 August 2010, http://search.informit.com.au/documentSummary;dn=430012692310760;res=IELHEA

Franklin ME; Anderson JM; Stocker SL; Pillans PI; Williams KM; Day RO; Taylor PJ, 2009, 'Measurement of Oxypurinol Concentrations in Urine by HPLC-Tandem Mass Spectrometry', in THERAPEUTIC DRUG MONITORING, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Montreal, pp. 640 - 640, presented at 11th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, CANADA, Montreal, 03 October 2009 - 08 October 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270484600142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Botch B; Day RO; Vining WJ; Hixson S; Samal P; Hart D; Peterfreund A; Rath KA, 2005, 'ChemPrep: Self-paced owl preparation for general chemistry and organic chemistry', in ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC, CA, San Diego, pp. U346 - U346, presented at 229th National Meeting of the American-Chemical-Society, CA, San Diego, 13 March 2005 - 17 March 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000228177702047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Day RO; Lamont GB, 2005, 'Extended multi-objective fast messy genetic algorithm solving deception problems', in Coello CAC; Aguirre AH; Zitzler E (eds.), EVOLUTIONARY MULTI-CRITERION OPTIMIZATION, SPRINGER-VERLAG BERLIN, MEXICO, Guanajuato, pp. 296 - 310, presented at 3rd International Conference on Evolutionary Multi-Criterion Optimization (EMO 2005), MEXICO, Guanajuato, 09 March 2005 - 11 March 2005

Lipani JA; Strand V; Johnson K; Woodworth T; Furst D; Singh G; Day R; Brooks P, 2001, 'A proposal for developing a large patient population cohort for longterm safety monitoring in rheumatoid arthritis', in Journal of Rheumatology, pp. 1170 - 1173

Day RO, 2000, 'Cox 2 Inhibitors and safety', in Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Newcastle, pp. 1.12, presented at ASCEPT: 34th Annual Scientific Meeting, Newcastle

Day RO; Bombardier C; Laine L; Reicin A; Ramey D; Brett C, 2000, 'Fewer Gastrointestinal Protective Agents, Procedures & Hospitalisations with Rofecoxib vs. Naproxen in the Vigor (VIOXXX GI Outcomes Research) Study', in Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Newcastle, pp. 6.35, presented at ASCEPT: 34th Annual Scientific Meeting, Newcastle

Bombardier C; Laine L; Hochberg M; Day R; Connors L; Shapiro D; Reicin A, 2000, 'A prospective double-blind GI outcomes study of rofecoxib vs. naproxen.', in ARTHRITIS AND RHEUMATISM, LIPPINCOTT WILLIAMS & WILKINS, pp. S225 - S225

Back to profile page